Most people think of brain health in terms of MRI and CT scans, but QuantalX is marrying transcranial magnetic stimulation with EEG such that clinicians can now measure individual brain function against QuantalX’s database of healthy brains and monitor changes over time. Both neurologists and psychiatrists can benefit from the device and associated software as a medical device, said Dr. Iftach Dolev, CEO of the company, in the MedCity Pivot Podcast. The company’s Delphi-MD device recently won a de novo FDA clearance.

This episode is sponsored By Claritev. Claritev’s healthcare technology solutions and data-driven insights improve affordability, transparency, and quality across the healthcare ecosystem.

Here’s audio of the podcast:

Here’s the video of our interview:

Here’s an AI -create

See Full Page